GLP-1 Therapies Research Papers

5 days ago • Frontiers in neuroanatomy

How GLP-1 signals in the brain's reward center may influence reward and metabolismNucleus accumbens GLP-1 signaling and its role in reward and metabolic regulation: a systematic review.

📖 Top 20% JournalSystematic Review

6 days ago • Frontiers in endocrinology

Dietary fibers that may increase natural GLP-1 levels and feelings of fullnessDietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review.

🎖️ Top 10% JournalSystematic Review

6 days ago • Frontiers in endocrinology

Short-term oleoylethanolamide (TRPTI™) supplements increase gut hormone responsesAcute TRPTI™ (oleoylethanolamide) supplementation enhances incretin hormone responses: a fixed-sequence crossover study.

🎖️ Top 10% JournalRandomized Controlled Trial

1 week ago • International journal of molecular sciences

Links Between GLP-1 Treatments and Gum Health: A Review of Current Findings and Future DirectionsRelationship Between GLP-1-Based Therapies and Periodontal Health: A Systematic Review of Current Evidence and Future Perspectives.

📖 Top 20% JournalSystematic Review

1 week ago • Frontiers in endocrinology

Tirzepatide and fatty liver disease linked to metabolism in people with obesity: a real-world multicenter studyTirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study.

🎖️ Top 10% JournalMulticenter Study

1 week ago • Nature metabolism

Different brain areas control eating when GIP receptors are activated or blockedDistinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism.

🥇 Top 1% Journal

1 week ago • Frontiers in oncology

Cancer outcomes and biological effects in type 2 diabetes patients treated with glucagon-like peptide-1 receptor agonistsCancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis.

📖 Top 20% JournalSystematic Review

5 days ago • Medicine

Semaglutide’s safety and effectiveness for weight loss in obese people without diabetesEffectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis.

📖 Top 50% JournalSystematic Review

5 days ago • The bone & joint journal

Glucagon-like peptide-1 receptor agonists linked to better recovery within 90 days after hip and knee replacement surgeryGlucagon-like peptide-1 receptor agonists are associated with improved 90-day outcomes after total hip and knee arthroplasty : a systematic review and meta-analysis.

🥉 Top 5% JournalSystematic Review

1 week ago • Drug design, development and therapy

Real-world weight loss with different GLP-1 medicines in the All of Us studyReal-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study.

📖 Top 20% JournalComparative Study

3 weeks ago • Nature metabolism

Stopping GLP-1RA treatment linked to higher risk of depression and anxiety in people with type 2 diabetesAssociation of GLP-1RA discontinuation and risk of depressive and anxiety disorders in people with type 2 diabetes: a cohort study.

🥇 Top 1% Journal

5 days ago • Clinical pharmacology and therapeutics

Patterns of Prescriptions for Glucagon-Like Peptide-1 Drugs and Their Links to Mental Health ConditionsPrescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.

🥉 Top 5% JournalArticle

1 week ago • Frontiers in endocrinology

Tirzepatide's effects on body weight and body fat in adults with overweight and obesityEffects of tirzepatide therapy on body weight and body composition in adults with overweight and obesity.

🎖️ Top 10% Journal

3 weeks ago • Journal of clinical medicine

Comparing GLP-1 or GLP-1/GIP Drugs with SGLT2 Inhibitors in Patients with Irregular Heartbeat and Preserved Heart FunctionGLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.

📖 Top 20% Journal

4 weeks ago • Journal of diabetes

Comparing Real-World and Clinical Trial Results for Incretin-Based Diabetes TreatmentsReal-World vs. Randomized Trial Evidence for Incretin-Based Therapies: A Narrative Review.

📖 Top 20% Journal

1 week ago • PloS one

Changes in heart and metabolism health and energy balance after stopping semaglutide treatmentImpact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol.

📖 Top 30% JournalClinical Trial Protocol

6 days ago • Pharmaceutical research

Impurities and Possible Immune Reactions Linked to Generic and Mixed Versions of Glucagon-like Peptide-1 Receptor AgonistsImpurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists.

📖 Top 20% JournalArticle

6 days ago • Lancet (London, England)

Effectiveness and safety of once-daily oral zenagamtide, a new combined GLP-1 and amylin receptor drug, in adults with type 2 diabetes: a multi-center, randomized, placebo-controlled dose studyEfficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

🥇 Top 1% JournalArticle

1 week ago • The American journal of psychiatry

Testing Oral Semaglutide as a Treatment for Alcohol Use DisorderOral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial.

🥇 Top 1% JournalArticle

1 week ago • Obesity pillars

Primary Care Doctors' Opinions on Helping Patients Who Lose Insurance for Weight-Loss Drugs Based on Glucagon-Like Peptide-1A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management.

📖 Top 20% Journal

2 weeks ago • Drugs

Orforglipron: First Approval for Medical UseOrforglipron: First Approval.

🥈 Top 2% Journal

2 weeks ago • BMJ open

Link between GLP-1 receptor drugs and alcohol-related hospital visits in adults with alcohol use disorderAssociation between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.

📖 Top 20% Journal

2 weeks ago • The Journal of clinical psychiatry

GLP-1 Receptor Agonists and Risk of Any Overdose in Veterans with Type 2 Diabetes and Opioid Use DisorderGLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.

🎖️ Top 10% Journal

2 weeks ago • EClinicalMedicine

Effectiveness and safety of HRS-7535, an oral diabetes drug, in people with diabetic kidney diseaseEfficacy and safety of HRS-7535, an oral small-molecule GLP-1 receptor agonist, in patients with diabetic kidney disease (SOLID-DKD): a randomised, double-blind, placebo-controlled, phase 2 trial.

🥈 Top 2% Journal

3 weeks ago • The lancet. Psychiatry

Links between GLP-1 receptor drugs and hospital stays for alcohol and drug problems during and after treatmentAssociation of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study.

🥇 Top 1% Journal

3 weeks ago • Obstetrics and gynecology

Links Between Diabetes Drugs and Menstrual Changes in Women of Reproductive AgeAssociation of Glucagon-Like Peptide-1 Receptor Agonists With Menstrual Events in Reproductive-Aged Patients.

🥉 Top 5% Journal

4 weeks ago • JACC. Heart failure

Tirzepatide's effects on obesity-related heart failure with preserved pumping function differ by sexEffects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial.

🥇 Top 1% Journal

2 days ago • The Journal of the Association of Physicians of India

Real-World Experiences Using Semaglutide at a Hospital in JharkhandSemaglutide in Practice: Insights from a Retrospective Case Series at a Jharkhand Tertiary Care Hospital.

Observational Study

2 days ago • Microbiology spectrum

Liraglutide's effects on changes in gut bacteriaEffects of liraglutide on gut bacterial community dynamics.

📖 Top 20% JournalArticle

4 days ago • Biology methods & protocols

Semaglutide use linked to milder COVID-19 and flu with improved kidney health after infectionSemaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection.

📖 Top 30% JournalArticle

← prevpage 1 of 14next →